Description
Tirzepatide (CAS 2023788-19-2) is a research-grade peptide supplied exclusively for in-vitro laboratory studies.
This product is a synthetic analog with dual agonist activity at the gastric inhibitory polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. Its molecular structure incorporates a C-20 fatty diacid moiety that facilitates albumin binding for extended stability in research applications.
Each vial contains lyophilized powder with ≥99% purity as confirmed by high-performance liquid chromatography (HPLC) and mass spectrometry (MS). Batch-specific Certificates of Analysis are available for download.
FOR RESEARCH USE ONLY. Not for human consumption, veterinary use, or any application in or on the body.




Reviews
There are no reviews yet.